RedHill Biopharma (RDHL) Operating Margin Growth (3y) (2015 - 2023)
RedHill Biopharma (RDHL) Operating Margin Growth (3y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 293,306.00 |
| Mar 31, 2023 | -241,937.00 |
| Dec 31, 2022 | -133,169.00 |
| Sep 30, 2022 | -66,214.00 |
| Jun 30, 2022 | -74,214.00 |
| Mar 31, 2022 | -40,350.00 |
| Dec 31, 2021 | -138,043.00 |
| Sep 30, 2021 | -36,083.00 |
| Jun 30, 2021 | -29,094.00 |
| Mar 31, 2021 | -32,057.00 |
| Dec 31, 2020 | -62,611.00 |
| Sep 30, 2020 | -84,790.00 |
| Jun 30, 2020 | -274,329.00 |
| Mar 31, 2020 | 20.37 Mn |
| Dec 31, 2019 | -825,213.00 |
| Dec 31, 2018 | -892,529.00 |
| Jun 30, 2018 | -58.86 Mn |
| Dec 31, 2017 | -48.07 Mn |
| Sep 30, 2017 | 84,549.00 |
| Jun 30, 2017 | 280,300.00 |